Chronic cough, defined as a cough persisting for more than eight weeks, presents a diagnostic and therapeutic challenge for clinicians. Despite its prevalence, the approach to chronic cough often lacks a systematic and comprehensive strategy, leading to delayed diagnosis and suboptimal management.
Initially, clinicians should differentiate between cough-variant asthma, gastroesophageal reflux disease, and upper airway cough syndrome, the three most common causes of chronic cough. A comprehensive medical history, physical examination, and judicious use of investigations like spirometry, chest radiographs, and upper gastrointestinal endoscopy can guide diagnosis. Additionally, the role of newer diagnostic modalities, such as impulse oscillometry and laryngeal sensory testing, is expanding.
Treatment should be etiology-specific and patient-centered. Empiric treatment trials can be considered when the diagnosis is uncertain. For cough-variant asthma, inhaled corticosteroids are the mainstay of treatment. Proton pump inhibitors are recommended for gastroesophageal reflux disease-associated cough, while antihistamines and nasal corticosteroids can be used for upper airway cough syndrome. Refractory cases may benefit from neuromodulatory agents like gabapentin and pregabalin.
Recent research has shed light on the phenomenon of cough hypersensitivity syndrome, a condition where cough receptors in the airway become hypersensitive, leading to chronic cough. This has opened new avenues for the development of novel therapeutic agents targeting the cough reflex pathway, such as P2X3 receptor antagonists.
In conclusion, a comprehensive and systematic approach to chronic cough is essential for accurate diagnosis and effective management. Emerging concepts and novel therapeutic agents promise to transform the landscape of chronic cough management in the future. Clinicians need to stay abreast of these developments to provide optimal care for patients with chronic cough.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation